CLSI I/LA32-P

Newborn Screening by Tandem Mass Spectrometry; Proposed Guideline, I/LA32P

Clinical and Laboratory Standards Institute, 11/01/2009

Publisher: CLSI

File Format: PDF

$102.00$205.99

Description

Published:01/11/2009

Pages:78

CLSI I/LA32-P serves as a reference source for the numerous activities related to operating a tandem mass spectrometry laboratory as part of public and private newborn screening programs with the goal of creating greater test accuracy, performance, and consistency among laboratories, thereby ensuring data quality that will ultimately benefit all newborns worldwide.

More CLSI standard pdf

CLSI M45-A2

Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria; Approved Guideline-Second Edition, M45A2E

$114.00 $228.69

CLSI M53-P

Criteria for Laboratory Testing and Diagnosis of HIV Infection; Proposed Guideline, M53P

$145.00 $291.15

CLSI EP28-A3cS (R2018)

Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory; Approved Guideline, Third Edition, EP28A3E

$90.00 $180.00

CLSI I/LA32-A

Newborn Screening by Tandem Mass Spectrometry; Approved Guideline, ILA32A

$140.00 $281.86